lobbying_activities: 1145562
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1145562 | c72e8950-7683-4433-82f7-e49d60cf335e | Q3 | DALRYMPLE & ASSOCIATES, LLC | 5073 | BRIGHTON BIOTECH, INC. | 2011 | third_quarter | DEF | Small molecule CBRN threat medical countermeasure research and development defense agency funding legislation, appropriations and oversight. | Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 16000 | 0 | 0 | 2011-10-07T14:54:35.007000-04:00 |